Scharf Investments’s GSK GSK Stock Holding History

Scharf Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-7,564	Closed	-$472K	–	40
2013 Q2	$472K	Buy	+7,564	New	+$480K	0.03%	38

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Scharf Investments's GSK Position: Q3 2013 in Review

Scharf Investments sold out of GSK (GSK) in Q3 2013, closing a stake of 7,564 shares — an estimated $472K sold.

Scharf Investments first reported a position in GSK in Q2 2013 and held it in 1 quarter. The position peaked at $472K in Q2 2013. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

Scharf Investments reported no remaining GSK position as of Q3 2013 after selling out during the quarter.
Scharf Investments sold 7,564 GSK shares in Q3 2013, an estimated $472K.
Scharf Investments first reported a position in GSK in Q2 2013 and held it in 1 quarter.
Scharf Investments's GSK position peaked at $472K in Q2 2013.
635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Scharf Investments's 13F filing for Q3 2013, filed 14 Nov 2013.